logo
Scientists Find that Hosing Glizzies Is Basically a Death Sentence

Scientists Find that Hosing Glizzies Is Basically a Death Sentence

Yahoo4 days ago
As millions of Americans stock up on hot dogs ahead of Independence Day, researchers have some bad news: those franks are deadly — no tails, snouts, or butts about it.
The tragic news comes from a survey published in Nature Medicine, an esteemed biomedical research journal. Combing over 60 previous nutrition studies on processed foods — specifically cured meat, sugary drinks, and trans fatty acids, all staples of the North American diet — researchers determined there's "no safe amount" of processed food humans can eat.
The survey established an iron-clad link between the consumption of those three foodstuffs and chronic diseases like type 2 diabetes, ischemic heart disease, and colon cancer.
For example, the data showed that even eating one hot dog a day leads to an 11 percent greater risk of type 2 diabetes, and a seven percent increased risk of colon cancer, compared to non-glizzy guzzlers.
"This current research has shown, yet again and consistent with prior research… that to achieve health gains it is best to avoid or minimize the habitual consumption of each of processed meat, sugar-sweetened beverages, and industrially produced trans fatty acids," Dr. Nita Forouhi, head of nutritional epidemiology at the University of Cambridge, told CNN.
While the science seems sound, decoupling America from the humble frankfurter may be easier said than done.
According to the National Hot Dog and Sausage Council (NHDSC) — arguably a biased source — the US collectively consumes anywhere between 9 and 20 billion hot dogs per year. It's estimated that some 150 million of those are eaten on the 4th of July alone.
Meanwhile, a 2021 survey reported by BEEF Magazine — seriously, who else has this kind of data? — found that 73 percent of Americans believe hot dogs are "essential to a cookout."
Of course, hot dogs are just one of many things consumed around the world that aren't necessarily "good" for you. But for Jamie Loftus, the author of "Raw Dog: The Naked Truth About Hot Dogs," the glizzy is the perfect avatar to represent everything wrong with the industrial meat industry.
In her book, Loftus follows the frank along its entire lifecycle, detailing the depression-era roots of the hot dog, the role of hot dog eating competitions, the horrors of factory farming, and the lack of federal oversight over meat industry labor conditions.
It's not a pretty story, to put it mildly, but it is an important reflection on the state of food in the United States — especially in light of the fact that glizzies are literally killing us.
Joey Chestnut did not respond to a request for comment.
More on Food: Famous Chef Boasts That He's Using AI to Invent New Recipes
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

FDA Declines to Approve New Melanoma Therapy
FDA Declines to Approve New Melanoma Therapy

Medscape

time22 minutes ago

  • Medscape

FDA Declines to Approve New Melanoma Therapy

The FDA has declined to approve a new oncolytic immunotherapy, vusolimogene oderparepvec (RP1), to treat advanced melanoma. The agency recently issued a complete response letter to the company, Replimune Group, rejecting its biologics license application that sought approval for the new agent in combination with nivolumab (Opdivo) to treat adults with advanced melanoma. In the complete response letter, the FDA indicated that it can't approve the biologics license application for vusolimogene oderparepvec because the company's IGNYTE trial 'is not considered to be an adequate and well-controlled clinical investigation that provides substantial evidence of effectiveness,' Replimune explained in a press release. According to Replimune, the complete response letter also noted that the trial data 'cannot be adequately interpreted due to the heterogeneity of the patient population,' and that 'there are items related to the confirmatory trial study design which need to be addressed.' 'We are surprised by the FDA decision and disappointed for advanced melanoma patients who have limited treatment options, as highlighted by the granting of breakthrough status at the time we provided the IGNYTE primary data,' stated Sushil Patel, PhD, Replimune's chief executive officer. Vusolimogene oderparepvec is the lead product candidate for the biotech company. Patel further noted that the issues raised in the complete response letter were not 'raised by the agency in mid- and late-cycle reviews.' Additionally, he said, 'we had also aligned on the design of the confirmatory study.' The FDA's response to the biologics license application for the new agent, along with its recently announced policy requiring randomized, controlled trials for approval of COVID vaccines in healthy Americans younger than 65 years, may signal that the agency is taking a tougher stance on new drug approvals. Replimune plans to 'urgently interact with the FDA to find a path forward for the timely accelerated approval of RP1,' according to its statement. Sharon Worcester, MA, is an award-winning medical journalist based in Birmingham, Alabama, writing for Medscape Medical News, MDedge, and other affiliate sites. She currently covers oncology, but she has also written on a variety of other medical specialties and healthcare topics. She can be reached at sworcester@ or on X @SW_MedReporter.

How much the COVID-19 pandemic aged our brains
How much the COVID-19 pandemic aged our brains

Yahoo

timean hour ago

  • Yahoo

How much the COVID-19 pandemic aged our brains

NEW HAVEN, Conn. (WTNH) — In today's Health headlines, how much the COVID-19 pandemic aged our brains, the connection between sleep and alcohol consumption in young adults, and how high blood pressure impacts breastfeeding outcomes. Dr. F. Perry Wilson, associate professor at Yale School of Medicine, Yale Medicine physician, and author of 'How Medicine Works and When It Doesn't,' joined Good Morning Connecticut at 9 a.m. to discuss. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Marcus Smart gives an update on his health issues
Marcus Smart gives an update on his health issues

Yahoo

timean hour ago

  • Yahoo

Marcus Smart gives an update on his health issues

Plenty of people are optimistic and even excited about Marcus Smart joining the Los Angeles Lakers. The veteran guard is just three calendar years removed from winning the Defensive Player of the Year award, and he is also a capable ball handler and playmaker who possesses high basketball IQ. But one legitimate concern surrounding him is his health. He played in just 54 games during the past two seasons due to multiple injuries, including a finger problem and an ankle ailment. His inability to stay healthy lately has led some to believe that he simply isn't close to the same player he was just a few years ago. While on the "Sedano & Kap Show" on ESPN 710, Smart said he's just about ready to go in terms of his health. 'If I had to give a percentage I would say I'm a high-90s. I've been dealing with a finger, everybody knows I've been dealing with this finger injury. But I've been cleared to get back to basketball activities and I've been in the gym working and I'm excited to go so we'll see.' It is generally expected that Smart, who is 31 years of age, will significantly upgrade L.A.'s perimeter defense, which has been anemic over the last few years. He officially signed a two-year, $11 million contract on Tuesday after he cleared waivers following the buyout of his previous contract with the Washington Wizards. He has made the All-Defensive first team three times and has career averages of 10.6 points, 4.6 assists and 1.6 steals a game over his 11 seasons in the NBA. This article originally appeared on LeBron Wire: Marcus Smart gives an update on his health issues

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store